Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in ...
The firm’s CEO cited a “very competitive” recruiting market in 2024, but forecasts a better 2025 as longer-term efforts pay ...
Stifel chief executive Ron Kruszewski said surging markets have forced firms to be particularly choosy about which advisors ...
Barry Bannister, Stifel chief equity strategist, joins 'Power Lunch' to discuss the bad signs for the market and the DeepSeek ...
Stifel analyst Rick Wise upgraded Edwards Lifesciences (EW) to Buy from Hold with a price target of $90, up from $75. The firm said that TAVR, ...
The team of three advisors have started a firm called T6 Wealth Management, which will operate out of Morgan Stanley's new ...
After the market closed yesterday, Stifel published new coverage on Datadog. The firm downgraded its rating on the stock from ...
Stifel Nicolaus analyst Ian Gillies maintained a Buy rating on Badger Infrastructure Solutions (BADFF – Research Report) today and set a price ...